{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-05",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0173-0859",
      "generic_name": "fluticasone furoate and vilanterol trifenatate",
      "labeler_name": "GlaxoSmithKline LLC",
      "brand_name": "Breo Ellipta",
      "active_ingredients": [
        {
          "name": "FLUTICASONE FUROATE",
          "strength": "100 ug/1"
        },
        {
          "name": "VILANTEROL TRIFENATATE",
          "strength": "25 ug/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0173-0859-10",
          "description": "1 TRAY in 1 CARTON (0173-0859-10)  / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER",
          "marketing_start_date": "20130826",
          "sample": false
        },
        {
          "package_ndc": "0173-0859-14",
          "description": "1 TRAY in 1 CARTON (0173-0859-14)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER",
          "marketing_start_date": "20130826",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "GlaxoSmithKline LLC"
        ],
        "rxcui": [
          "1424889",
          "1424899",
          "1539891",
          "1539893",
          "1648783",
          "1648785",
          "1648788",
          "1648789",
          "2637473",
          "2637476"
        ],
        "spl_set_id": [
          "96428df1-ea05-431a-98d3-1ec2c4b63878"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "JS86977WNV",
          "40AHO2C6DG"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "POWDER",
      "spl_id": "10ccfa0a-0453-41bd-b092-d62863a82c26",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "RESPIRATORY (INHALATION)"
      ],
      "marketing_start_date": "20130826",
      "product_id": "0173-0859_10ccfa0a-0453-41bd-b092-d62863a82c26",
      "application_number": "NDA204275",
      "brand_name_base": "Breo Ellipta",
      "pharm_class": [
        "Adrenergic beta2-Agonists [MoA]",
        "Corticosteroid Hormone Receptor Agonists [MoA]",
        "Corticosteroid [EPC]",
        "beta2-Adrenergic Agonist [EPC]"
      ]
    }
  ]
}